Article
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
2021-04-01
Abstract excerpt
SARS-CoV-2 entry is mediated by the spike (S) glycoprotein which contains the receptor-binding domain (RBD) and the N-terminal domain (NTD) as the two main targets of neutralizing antibodies (Abs). A novel variant of concern (VOC) named CAL.20C (B.1.427/B.1.429) was originally detected in California and is currently spreading throughout the US and 29 additional countries. It is unclear whether antibody responses t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3ae18a41-302f-5fa3-9198-9310e9e1536e
- DOI
- 10.1101/2021.03.31.437925
